15-min delayed · Jul 21, 8:00 AM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering XOMA Royalty Corporation, 2 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $39.00 to $76.00, a moderate spread. The average target of $55.00 sits 37% above the current $40.17. The rating mix has held broadly steady over recent months.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy267%
Hold133%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to XOMA Royalty Corporation.
As of Jul, 2 of 3 firms rate XOMA a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
XOMA EPS & revenue forecast
EPS · NEXT QUARTER
$0.52
Range $0.52 – $0.52 · 1 analysts · -26% YoY
Next period, 1 analysts expect XOMA Royalty Corporation to earn $0.52 a share (range $0.52 – $0.52), versus $0.70 a year earlier. Full-year consensus is $0.55.
REVENUE · NEXT QUARTER
$16.4M
Range $16.4M – $16.4M · 1 analysts · +76% YoY
Revenue is expected to reach $16.4M (range $16.4M – $16.4M), +75.6% year-over-year. Full-year consensus is $65.0M, rising to $0 next year.
Top analysts covering XOMA Royalty Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on XOMA.
#1
RW
Robert Wasserman
Benchmark · Rank #259
Buy
$50.00+24.5% to target
Overall win rate
39%
+ Follow
#2
Joseph Pantginis
HC Wainwright & Co. · Rank #266
Hold
$39.00-2.9% to target
Overall win rate
32%
+ Follow
#3
David Risinger
Leerink Partners
Buy
$50.00+24.5% to target
Coverage
—
+ Follow
#4
JZ
Jason Zhuang
Leerink Partners
Buy
$50.00+24.5% to target
Coverage
—
+ Follow
#5
EP
Elemer Piros
LUCID CAPITAL MARKETS
Buy
$76.00+89.2% to target
Coverage
—
+ Follow
XOMA stock forecast FAQ
What is XOMA's average 12-month price target?+
The 3 analysts with a live target average $55.00 for XOMA Royalty Corporation over the next 12 months, ranging from a $76.00 high to a $39.00 low.
Is XOMA stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 2 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for XOMA?+
The Street-high target is $76.00 (LUCID CAPITAL MARKETS), and the Street-low is $39.00 (HC Wainwright & Co.). The average of all 3 active targets is $55.00.
How many Wall Street analysts cover XOMA?+
3 analysts have an active rating on XOMA Royalty Corporation, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering XOMA?+
Among analysts who currently cover XOMA, Robert Wasserman of Benchmark has the strongest overall Quantellect track record (Rank #259). Their current call is Buy with a $50.00 target.
What is XOMA Royalty Corporation's projected EPS for next quarter?+
The consensus estimate is $0.52 per share (range $0.52 – $0.52) across 1 analysts. Full-year EPS is projected at $0.55, rising to — the following year.
How much revenue is XOMA Royalty Corporation expected to report next quarter?+
Consensus revenue is $16.4M (range $16.4M – $16.4M). Full-year revenue is projected at $65.0M, growing to $0 next year.
Have analysts been upgrading or downgrading XOMA lately?+
As of Jul, 2 of 3 firms rate XOMA a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their XOMA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
